Search Instructions:
* Filter the ENTIRE resource library: Choose a Subject OR a Type of Item at the bottom of the page from the buttons to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (672 total)
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of CASIRIVIMAB and IMDEVIMAB
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-21
Description: Casirivimab and imdevimab to be administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct…
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-21
Description: Casirivimab and imdevimab to be administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct…
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
Creator: Infectious Diseases Society of America (IDSA)
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-22
Description: These are regularly updated guidelines on the treatment and management of patients with COVID-19.
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-22
Description: These are regularly updated guidelines on the treatment and management of patients with COVID-19.
Covid-19–Associated Myopathy Caused by Type I Interferonopathy
Creator: Manzano, Giovanna S., Jared K. Woods, and Anthony A. Amato.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-20
Description: The syndrome of Covid-19 infection includes myalgias and elevated creatine kinase levels in at least a third of patients. Whether the elevation in creatine kinase level is caused by viral infection of muscle, toxic effects of cytokines, or another…
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-20
Description: The syndrome of Covid-19 infection includes myalgias and elevated creatine kinase levels in at least a third of patients. Whether the elevation in creatine kinase level is caused by viral infection of muscle, toxic effects of cytokines, or another…
NETEC COVID-19 Webinar Series (11/25/20): Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Creator: Cavalcanti, Alexandre B., Fernando G. Zampieri, Regis G. Rosa, Luciano C. P. Azevedo, Viviane C. Veiga, Alvaro Avezum, Lucas P. Damiani, Aline Marcadenti, Letícia Kawano-Dourado, Thiago Lisboa, Debora L. M. Junqueira, Pedro G. M. de Barros e Silva,…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-11-19
Description: Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-11-19
Description: Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited.
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Creator: The RECOVERY Collaborative Group
Subject: Research
Item Type: Publication
Date Last Updated: 2020-11-19
Description: Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-11-19
Description: Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials.
Safe and Proper N95 Storage
Creator: NETEC
Subject: Infection Control
Item Type: Video
Date Last Updated: 2020-11-20
Description: Paper Bagging: How to properly and safely store your N95. This video shows an animation of the proper technique for safely storing your N95. Created by Emory VME (https://med.emory.edu/ppe) and NETEC (https://netec.org/).
Subject: Infection Control
Item Type: Video
Date Last Updated: 2020-11-20
Description: Paper Bagging: How to properly and safely store your N95. This video shows an animation of the proper technique for safely storing your N95. Created by Emory VME (https://med.emory.edu/ppe) and NETEC (https://netec.org/).
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of BARICITINIB
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-19
Description: EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or…
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-19
Description: EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or…
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-04-30
Description: EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-04-30
Description: EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.